drugset / Trial / NCT06038331

Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of STT Osteoarthritis

NCT06038331 ↗

Phase 2 Recruiting 14 enrolled TBF Genie Tissulaire
NaSingle-groupOpen-labelTreatment

Summary

The aim of this open, prospective, multicenter trial is to evaluate the use of a sterile, devitalized, processed umbilical cord amniotic membrane implant placed in joint interposition in the treatment of STT osteoarthritis.

Timeline

Start
2024-05-28
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject SclerFIX-IP Other / unclassified — —

Indications